A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy
Clinical trial NCT05808764 · COMPLETED
Trial details
- NCT number
- NCT05808764
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-26
- Primary completion
- 2026-05-04
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.